These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 21854223)
1. Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles. Minarini PR; de Souza AO; Soares EG; Barata LE; Silva CL; Bentley MV Drug Dev Ind Pharm; 2012 Mar; 38(3):259-63. PubMed ID: 21854223 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model. Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826 [TBL] [Abstract][Full Text] [Related]
6. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405 [TBL] [Abstract][Full Text] [Related]
7. Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size. de Steenwinkel JE; ten Kate MT; de Knegt GJ; Verbrugh HA; van Belkum A; Hernandez-Pando R; Bakker-Woudenberg IA Int J Tuberc Lung Dis; 2011 Nov; 15(11):1478-84, i. PubMed ID: 22008760 [TBL] [Abstract][Full Text] [Related]
8. Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes. Puras G; Salvador A; Igartua M; Hernández RM; Pedraz JL Eur J Pharm Sci; 2011 Oct; 44(3):200-6. PubMed ID: 21820509 [TBL] [Abstract][Full Text] [Related]
9. Development and characterization of rifampicin loaded floating microspheres. Goyal P; Gill S; Gupta UD; Rath G; Narang RK; Goyal AK Artif Cells Blood Substit Immobil Biotechnol; 2011 Oct; 39(5):330-4. PubMed ID: 21631389 [TBL] [Abstract][Full Text] [Related]
10. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone. da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313 [TBL] [Abstract][Full Text] [Related]
11. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
12. In vitro/in vivo evaluation of the efficiency of teicoplanin-loaded biodegradable microparticles formulated for implantation to infected bone defects. Yenice I; Caliş S; Atilla B; Kaş HS; Ozalp M; Ekizoğlu M; Bilgili H; Hincal AA J Microencapsul; 2003; 20(6):705-17. PubMed ID: 14594660 [TBL] [Abstract][Full Text] [Related]
13. Nanostructured microspheres produced by supercritical fluid extraction of emulsions. Della Porta G; Reverchon E Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122 [TBL] [Abstract][Full Text] [Related]
14. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis. Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598 [TBL] [Abstract][Full Text] [Related]
15. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
16. Gelatin nanocarriers as potential vectors for effective management of tuberculosis. Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis. Kumar G; Sharma S; Shafiq N; Pandhi P; Khuller GK; Malhotra S Drug Deliv; 2011 Jan; 18(1):65-73. PubMed ID: 20735202 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
19. Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles. Ahmad Z; Pandey R; Sharma S; Khuller GK Int J Antimicrob Agents; 2008 Feb; 31(2):142-6. PubMed ID: 18155883 [TBL] [Abstract][Full Text] [Related]
20. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin. Liang Y; Wu X; Zhang J; Li N; Yu Q; Yang Y; Bai X; Liu C; Shi Y; Liu Q; Zhang P; Li Z Vaccine; 2008 Aug; 26(35):4536-40. PubMed ID: 18602439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]